Viewing Study NCT03379259


Ignite Creation Date: 2025-12-24 @ 2:51 PM
Ignite Modification Date: 2025-12-26 @ 6:06 AM
Study NCT ID: NCT03379259
Status: TERMINATED
Last Update Posted: 2024-10-26
First Post: 2017-12-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors
Sponsor: BeiGene
Organization: